BioCentury This Week

Jeff Kramer

At a Glance

BioCentury This Week is hosted by Jeff Kramer covering RNAi, Antisense Oligonucleotides (ASO), Cardiovascular Disease, and Lipoprotein(a).

1 episodes25 total claims12 topics covered

1 episodes

Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules

Feb 3, 2026

›

Pivotal Phase 3 data for RNA-based therapies, particularly in cardiovascular disease with the Lp(a)-targeting drug Pella Carson, are expected in 2026, potentially validating new mechanisms and moda...

Neutral0 quotes0 findings

RNAiAntisense Oligonucleotides (ASO)Cardiovascular DiseaseLipoprotein(a)+16 more

BioCentury This Week

At a Glance

1 episodes

Top Topics